Stephen Rempe - Cardiovascular Systems Chief Officer
Insider
Stephen Rempe is Chief Officer of Cardiovascular Systems
| Age | 50 |
| Phone | 651 259 1600 |
| Web | https://www.csi360.com |
Cardiovascular Systems Management Efficiency
The company has return on total asset (ROA) of (0.0756) % which means that it has lost $0.0756 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1518) %, meaning that it created substantial loss on money invested by shareholders. Cardiovascular Systems' management efficiency ratios could be used to measure how well Cardiovascular Systems manages its routine affairs as well as how well it operates its assets and liabilities.Cardiovascular Systems currently holds 22.15 M in liabilities with Debt to Equity (D/E) ratio of 0.09, which may suggest the company is not taking enough advantage from borrowing. Cardiovascular Systems has a current ratio of 5.93, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Cardiovascular Systems' use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Michael Carter | Nevro Corp | 52 | |
| Laura MBA | Si Bone | 58 | |
| Erik Mickelson | Paragon 28 | 42 | |
| Ehab Esmail | Orthofix Medical | 53 | |
| Michael MD | Outset Medical | N/A | |
| Marco Dolci | LivaNova PLC | 62 | |
| Victoria Vezina | Rapid Micro Biosystems | 56 | |
| John Treace | Treace Medical Concepts | 53 | |
| David Haffner | Glaukos Corp | N/A | |
| B Johnson | Paragon 28 | 68 | |
| Brendan Shook | Paragon 28 | N/A | |
| Chi Nguyen | Neuropace | 47 | |
| Rajbir Denhoy | Establishment Labs Holdings | 54 | |
| James Mazzola | Outset Medical | N/A | |
| Jared Oasheim | CVRx Inc | 41 | |
| Jeffrey Bettinger | Establishment Labs Holdings | N/A | |
| Julie Dewey | Nevro Corp | 63 | |
| Thomas Timbie | Treace Medical Concepts | 66 | |
| Barbara Schwarzentraub | CONMED | 53 | |
| Nicole Shannon | Outset Medical | N/A | |
| BA Chemistry | Orthofix Medical | 63 | |
Management Performance
| Return On Equity | -0.15 | |||
| Return On Asset | -0.0756 |
Cardiovascular Systems Leadership Team
Elected by the shareholders, the Cardiovascular Systems' board of directors comprises two types of representatives: Cardiovascular Systems inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cardiovascular. The board's role is to monitor Cardiovascular Systems' management team and ensure that shareholders' interests are well served. Cardiovascular Systems' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cardiovascular Systems' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Philip Freed, VP Marketing | ||
| Stephen Rempe, Chief Officer | ||
| Jeffrey MD, Chief Officer | ||
| Peter Hirshman, VP Operations | ||
| Sandra Sedo, Chief Compliance Officer | ||
| Jeffrey Points, Chief Officer | ||
| BSc MS, Pres Chairman | ||
| Alexander Rosenstein, General Counsel and Corporate Secretary | ||
| John Nielsen, VP Communications |
Cardiovascular Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cardiovascular Systems a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.15 | |||
| Return On Asset | -0.0756 | |||
| Profit Margin | (0.16) % | |||
| Operating Margin | (0.16) % | |||
| Current Valuation | 466.13 M | |||
| Shares Outstanding | 42.2 M | |||
| Shares Owned By Insiders | 3.22 % | |||
| Shares Owned By Institutions | 89.64 % | |||
| Number Of Shares Shorted | 1.74 M | |||
| Price To Earning | 724.24 X |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in Cardiovascular Stock
If you are still planning to invest in Cardiovascular Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cardiovascular Systems' history and understand the potential risks before investing.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |